LACTOVID Trademark

Trademark Overview

On Wednesday, March 2, 2022, a trademark application was filed for LACTOVID with the United States Patent and Trademark Office. The USPTO has given the LACTOVID trademark a serial number of 97291309. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, February 18, 2025. This trademark is owned by University of Florida Research Foundation, Incorporated. The LACTOVID trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations comprised of diphenhydramine and lactoferrin for the treatment and prevention of Covid-19
lactovid

General Information

Serial Number97291309
Word MarkLACTOVID
Filing DateWednesday, March 2, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, February 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations comprised of diphenhydramine and lactoferrin for the treatment and prevention of Covid-19

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 12, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUniversity of Florida Research Foundation, Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGainesville, FL 32611
Party NameUniversity of Florida Research Foundation, Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGainesville, FL 32611

Trademark Events

Event DateEvent Description
Saturday, March 5, 2022NEW APPLICATION ENTERED
Monday, March 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 30, 2022ASSIGNED TO EXAMINER
Monday, December 12, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, December 12, 2022EXAMINERS AMENDMENT E-MAILED
Monday, December 12, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, December 12, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, December 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 5, 2023SOU EXTENSION 1 FILED
Tuesday, September 5, 2023SOU EXTENSION 1 GRANTED
Thursday, September 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 22, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 22, 2024SOU EXTENSION 2 GRANTED
Thursday, February 22, 2024SOU EXTENSION 2 FILED
Friday, February 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 18, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, February 18, 2025SOU EXTENSION 4 FILED
Tuesday, February 18, 2025SOU EXTENSION 4 GRANTED
Wednesday, February 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 30, 2024SOU EXTENSION 3 FILED
Friday, August 30, 2024SOU EXTENSION 3 GRANTED

Related Keywords

lactovid treatment prevention covid lactoferrin diphenhydramine pharmaceutical preparations comprised antiviral